The role of NO in contact hypersensitivity

被引:50
作者
Ross, R [1 ]
Reske-Kunz, AB [1 ]
机构
[1] Univ Mainz, Dept Dermatol, Clin Res Unit, D-55101 Mainz, Germany
关键词
nitric oxides; contact hypersensitivity; T lymphocytes;
D O I
10.1016/S1567-5769(01)00091-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Contact dermatitis or contact hypersensitivity (CHS) is a common T lymphocyte-mediated allergic disease characterized by local inflammatory skin reactions following contact with small reactive compounds called haptens. In common with other allergic processes, the development of contact dermatitis proceeds in two phases: a sensitization phase which occurs on first exposure to allergen, and an elicitation phase which occurs on subsequent exposure when the clinical manifestations of the disease are observed. This process is hapten-specific, While the pathophysiology of the sensitization phase is well characterized, Our understanding of the elicitation phase is still incomplete, including the relative contribution of the different effector cells and mediators involved. Here we summarize current knowledge of the contribution of nitric oxide (NO) to skin inflammation with special focus on CHS. A number of inflammatory stimuli trigger expression of NO in human and animal skin, and topical application of an NO-releasing cream results in inflammation. Moreover, expression of the inducible isoform of nitric oxide synthase (iNOS) is induced in CHS and iNOS inhibitors injected intradermally suppress CHS responses. However, iNOS-deficient mice develop an aggravated CHS response late in the elicitation phase, suggesting that NO is involved in downregulation of CHS. Based on these data, we propose a comprehensive model of the role of NO in CHS. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1469 / 1478
页数:10
相关论文
共 50 条
  • [21] Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses
    Anton V. Gorbachev
    Robert L. Fairchild
    Immunologic Research, 2001, 24 : 69 - 77
  • [22] Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses
    Gorbachev, AV
    Fairchild, RL
    IMMUNOLOGIC RESEARCH, 2001, 24 (01) : 69 - 77
  • [23] Obesity aggravates contact hypersensitivity reaction in mice
    Majewska-Szczepanik, Monika
    Kowalczyk, Paulina
    Marcinska, Katarzyna
    Strzepa, Anna
    Lis, Grzegorz J.
    Wong, F. Susan
    Szczepanik, Marian
    Wen, Li
    CONTACT DERMATITIS, 2022, 87 (01) : 28 - 39
  • [24] PENTOXIFYLLINE SUPPRESSES IRRITANT AND CONTACT HYPERSENSITIVITY REACTIONS
    SCHWARZ, A
    KRONE, C
    TRAUTINGER, F
    ARAGANE, Y
    NEUNER, P
    LUGER, TA
    SCHWARZ, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (04) : 549 - 552
  • [25] Effect of topical application of lipopolysaccharide on contact hypersensitivity
    Tanaka, Manami
    Kohchi, Chie
    Inagawa, Hiroyuki
    Ikemoto, Takeshi
    Hara-Chikuma, Mariko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 586 : 100 - 106
  • [26] Hailey-Hailey disease and contact hypersensitivity
    Lis-Swiety, Anna
    Brzezinska-Wcislo, Ligia
    Bergler-Czop, Beata
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2011, 28 (03): : 224 - 227
  • [27] Contact hypersensitivity and allergic contact dermatitis among school children and teenagers with eczema
    Czarnobilska, Ewa
    Obtulowicz, Krystyna
    Dyga, Wojciech
    Wsolek-Wnek, Katarzyna
    Spiewak, Radoslaw
    CONTACT DERMATITIS, 2009, 60 (05) : 264 - 269
  • [28] ROLE OF INTERFERON-GAMMA IN CONTACT HYPERSENSITIVITY ASSESSED IN INTERFERON-GAMMA RECEPTOR-DEFICIENT MICE
    SAULNIER, M
    HUANG, S
    AGUET, M
    RYFFEL, B
    TOXICOLOGY, 1995, 102 (03) : 301 - 312
  • [29] Bcl-3 puts the brakes on contact hypersensitivity
    Weighardt, Heike
    Foerster, Irmgard
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (04) : 971 - 974
  • [30] Preventive and therapeutic potential of placental extract in contact hypersensitivity
    Kim, Youn Son
    Park, Jang-June
    Sakoda, Yukimi
    Zhao, Yuming
    Hisamichi, Katsuya
    Kaku, Tai-ichi
    Tamada, Koji
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (10) : 1177 - 1184